Skip to main content

ADVERTISEMENT

Anja Farovik, PhD

This post hoc analysis explored the efficacy of brexpiprazole 2 or 3 mg/day in patients with agitation associated with Alzheimer’s dementia, based on presence or absence of psychosis at b...
10/26/2023